Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 24, 2009 - Issue 3
Submit an article Journal homepage
702
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease

Faizul AzamDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Seventh of October University, PO Box 2873Misurata, LibyaCorrespondence[email protected] [email protected]
,
Sandeep Kumar BarodiaDr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India
,
Tarique AnwerFaculty of Pharmacy, Jamia Hamdard, Hamdard NagarNew Delhi, 110062, India
&
M. M. AlamFaculty of Pharmacy, Jamia Hamdard, Hamdard NagarNew Delhi, 110062, India
Pages 808-817 | Received 16 Jun 2008, Accepted 20 Jul 2008, Published online: 01 Jun 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Faizul Azam, Honiwa Suliman Abodabos, Ismail M. Taban, Abdalla R. Rfieda, Danish Mahmood, Md Jamir Anwar, Shamshir Khan, Natalia Sizochenko, Giulio Poli, Tiziano Tuccinardi & Hamed I. Ali. (2019) Rutin as promising drug for the treatment of Parkinson’s disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies. Molecular Simulation 45:18, pages 1563-1571.
Read now
Faizul Azam, Bashir A. El-gnidi, Ismail A. Alkskas & Musa A. Ahmed. (2010) Design, synthesis and anti-Parkinsonian evaluation of 3-alkyl/aryl-8-(furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones against neuroleptic-induced catalepsy and oxidative stress in mice. Journal of Enzyme Inhibition and Medicinal Chemistry 25:6, pages 818-826.
Read now

Articles from other publishers (8)

Zhichao Zhong, Xingrui He, Jiamin Ge, Junlong Zhu, Chuansheng Yao, Hong Cai, Xiang-Yang Ye, Tian Xie & Renren Bai. (2022) Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification. European Journal of Medicinal Chemistry 237, pages 114378.
Crossref
Isabelle Waku, Mylena S. Magalhães, Camila O. Alves & Amanda R. de Oliveira. (2021) Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies. European Journal of Neuroscience 53:11, pages 3743-3767.
Crossref
Parvez Ali, Syed Ajaz K. Kirmani, Osamah Al Rugaie & Faizul Azam. (2020) Degree-based topological indices and polynomials of hyaluronic acid-curcumin conjugates. Saudi Pharmaceutical Journal 28:9, pages 1093-1100.
Crossref
Leenata Mandpe, Abhay Kyadarkunte & Varsha Pokharkar. (2013) Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential. Therapeutic Delivery 4:11, pages 1365-1383.
Crossref
Faizul Azam, Medapati Vijaya Vara Prasad & Neelaveni Thangavel. (2011) Structure-based design, synthesis, and molecular modeling studies of 1-(benzo[d]thiazol-2-yl)-3-(substituted aryl)urea derivatives as novel anti-Parkinsonian agents. Medicinal Chemistry Research 21:9, pages 2630-2643.
Crossref
Faizul Azam, Arwa M. Madi & Hamed I. Ali. (2012) Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A2A Receptors for the Treatment of Parkinson's Disease. Journal of Young Pharmacists 4:3, pages 184-192.
Crossref
Faizul Azam, Bashir A. El-gnidi & Ismail A. Alkskas. (2010) Combating oxidative stress in epilepsy: Design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides. European Journal of Medicinal Chemistry 45:7, pages 2817-2826.
Crossref
Faizul Azam. (2008) Synthesis of some urea and thiourea derivatives of naphtha[1,2-d]thiazol-2-amine as anti-Parkinsonian agents that cause neuroprotection against haloperidol-induced oxidative stress in mice. Medicinal Chemistry Research 18:4, pages 287-308.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.